What changes in brain activity are found in postpartum depression patients?
Postpartum depression (PPD) is a serious mental health condition affecting new mothers. Brain imaging studies show that PPD is associated with specific changes in brain activity, particularly in areas involved in emotion, memory, and sensory processing. A 2024 meta-analysis of 12 studies found that women with PPD have increased activity in some brain regions and decreased activity in others, compared to healthy mothers 3. These changes may help explain the mood and cognitive symptoms of PPD.
What the research says
A comprehensive meta-analysis of resting-state functional imaging studies, which measured brain activity at rest, identified key differences in PPD patients 3. The analysis found increased functional activity in the left inferior occipital gyrus (involved in visual processing) and the left precuneus (part of the default mode network, linked to self-reflection and memory). Conversely, decreased activity was found in the right amygdala (a key region for emotion processing) and the left precentral gyrus (involved in motor control) 3. These alterations overlapped with brain systems that use serotonin, dopamine, and other neurotransmitters, suggesting a biological basis for PPD 3.
Another study using dynamic functional connectivity (how brain regions communicate over time) found that women with PPD and comorbid anxiety showed increased activity fluctuations in the subgenual anterior cingulate cortex (sgACC), a region involved in mood regulation 11. Women with PPD alone had increased static connectivity between the sgACC and the ventral anterior insula, which processes bodily sensations and emotions 11. Both groups showed disrupted connectivity between the sgACC and the middle temporal gyrus, a region linked to social cognition 11.
Animal research also supports these findings. In a rat study, postpartum females showed reduced activity in dopamine neurons in the ventral tegmental area (VTA), a brain region critical for reward and motivation, during the early postpartum period 10. This reduced activity was associated with increased anxiety-like behavior and reduced social motivation, mirroring symptoms of PPD 10.
Additionally, the FDA-approved drug zuranolone (Zurzuvae) for PPD works by modulating GABA-A receptors, highlighting the role of the GABA neurotransmitter system in PPD 5. This aligns with the meta-analysis finding that PPD-related brain changes involve neurotransmitter systems 3.
What to ask your doctor
- Could my symptoms of postpartum depression be related to changes in brain chemistry or activity?
- Are there treatments, like zuranolone or therapy, that target the specific brain changes seen in PPD?
- How do brain imaging findings help guide treatment decisions for postpartum depression?
- Should I consider a referral to a psychiatrist who specializes in postpartum mental health?
This question is drawn from common patient questions about this topic and answered using cited medical research. We do not provide individualized advice.